Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 89
Filter
1.
Dtsch Med Wochenschr ; 149(12): 679-683, 2024 Jun.
Article in German | MEDLINE | ID: mdl-38781990

ABSTRACT

Several catheter-based systems have been developed for interventional recanalization of pulmonary embolism. These include local ultrasound assisted thrombolysis (EKOS), in-toto-thrombectomy via retriever and aspiration system (FlowTriever) and the Indigo mechanical aspiration system. Safety and efficacy in the removal of thrombus have been demonstrated for all systems. Interventional recanalization strategies for high- and intermediate-high risk pulmonary embolism are potentially more effective in the removal of thrombus and restoration of right heart function than systemic thrombolysis with a lower risk of major bleeding complications. Preliminary data from registries and observational studies are very promising whereas the evidence for systemic thrombolysis treatment in high and intermediate-high risk pulmonary embolism is low. Randomized controlled clinical trials are currently performed comparing catheter based interventional therapies to systemic thrombolysis for the treatment of intermediate-high risk pulmonary embolisms. Primary outcome measurements include mortality, hemodynamic collapse, and major bleedings. Results are expected in 2025. The introduction of interventional therapies for pulmonary embolism was accompanied by an increased awareness of the complexity of pulmonary embolism management. The need for specialized interdisciplinary pulmonary embolism response teams (PERT-teams) and a well-structured approach including a PDCA cycle was recognized.


Subject(s)
Pulmonary Embolism , Thrombectomy , Thrombolytic Therapy , Pulmonary Embolism/therapy , Humans
2.
Acta Gastroenterol Belg ; 86(2): 383-384, 2023.
Article in English | MEDLINE | ID: mdl-37428178

ABSTRACT

A 69-year-old male with a past medical history of an Olfactory nerve meningioma and left-sided Bell's palsy presented with 6 weeks of lower abdominal pain and weight loss of 4 kg in 6 months. His current medications included acetylsalicylic acid 80 mg once daily, Amlodipine 5 mg once daily and Allopurinol 300 mg once daily. Physical examination was benign without signs of acute abdomen. The abdomen was nondistended and soft but tender to palpation over the left lower quadrant. Laboratory studies showed no acute outliers. The patient was followed up by his pulmonologist because of thoracic lesions which required a PET-CT for further evaluation. This PET-CT revealed a focal zone of oedematous rectosigmoid colon with a strong suspicion of a semi-circular sigmoid neoplasia with continuation to the bladder (Figure 1a). A presumptive diagnosis of a primary colonic malignancy was made. Colonoscopy was performed and visualised a foreign linear object lodged in both walls of the diverticular sigmoid with surrounding inflammation, but otherwise normal mucosa (Figure 1b). No arguments could be made endoscopically to support the diagnosis of an underlying primary colonic malignancy.


Subject(s)
Colonic Neoplasms , Positron Emission Tomography Computed Tomography , Male , Humans , Aged , Colon, Sigmoid/diagnostic imaging , Colonoscopy , Colonic Neoplasms/pathology
4.
Acta Gastroenterol Belg ; 83(4): 639-642, 2020.
Article in English | MEDLINE | ID: mdl-33321022

ABSTRACT

INTRODUCTION: Bifurcation of the pancreatic duct is a very rare anomaly and clinical significance is not known. Literature on this topic is scarce. We present two similar case reports with bifurcation of the main pancreatic duct from the body to the tail of the pancreas. Both cases were symptomatic, one had acute pancreatitis and the other recurrent pancreatitis. In both cases the most ventral duct was aberrant as a consequence of pancreatitis. DISCUSSION: We performed a literature study and found 22 relevant articles containing 26 case reports, of these cases, 12 were considered asymptomatic and were found incidentally, the other 14 cases were symptomatic with signs of acute, chronic or recurrent pancreatitis. To our knowledge this is the first article with a summary of previous published data on the subject. CONCLUSION: Bifurcation of the pancreatic duct seems to be a possible cause of pancreatitis, but a large group remains asymptomatic. Since diagnosis is often difficult, the incidence is probably underestimated. More attention to this anomaly is recommended. Further reports are needed to draw conclusion.


Subject(s)
Pancreatic Ducts , Pancreatitis, Chronic , Acute Disease , Humans , Pancreas/diagnostic imaging
5.
Acta Gastroenterol Belg ; 83(2): 331-333, 2020.
Article in English | MEDLINE | ID: mdl-32603056

ABSTRACT

In this paper we present the case of a male 55-year old patient with known ulcerative colitis and nodular regenerative hyperplasia, a rare form of noncirrhotic portal hypertension. He presented four visits to the emergency department with rapidly progressive anal discomfort. After two weeks a transjugular intrahepatic portosystemic shunt was placed using the gun-sight technique with immediate relief of the unbearable anal pain and pressure. To our knowledge, this is the first case where transjugular intrahepatic portosystemic shunt placement is applied for non- bleeding, congestive anorectal varices.


Subject(s)
Gastrointestinal Hemorrhage , Portasystemic Shunt, Transjugular Intrahepatic , Varicose Veins , Anal Canal , Gastrointestinal Hemorrhage/therapy , Humans , Hyperplasia , Male , Middle Aged , Rectum , Varicose Veins/therapy
6.
Vasa ; 49(5): 382-388, 2020 Aug.
Article in English | MEDLINE | ID: mdl-32605534

ABSTRACT

Background: The RECcording COurses of vasculaR Diseases (RECCORD) registry established by the German Society of Angiology - Society for Vascular Medicine aimed to address the lack in contemporary real-world data regarding current practice of medical and interventional care in vascular patients. We herein report the demographic and procedural characteristics of the first 1000 patients undergoing endovascular revascularization (EVR) for symptomatic peripheral artery disease (PAD). Patients and methods: RECCORD is an observational, prospective, multicenter, all-comers registry. Only patients undergoing EVR for symptomatic PAD are included and followed up for at least 1 year. Demographic characteristics, comorbidities, previous peripheral vascular interventions, medication, clinical stage of lower extremity artery disease (Rutherford category), hemodynamic parameters, and procedural data including complications are recorded via an entirely web-based platform. Results: Of the first 1000 patients (mean age 70 ± 10 years, 35% female) with 1096 EVR at 1477 vascular segments of the lower extremities, 25.0% were at the stage of chronic limb threatening ischemia (CLTI) and 75.0% at non-CLTI. The femoropopliteal segment was the dominant target lesion site (61.0%), followed by iliac (26.4%) and below-the-knee EVR (10.3%). Only angioplasty was performed in 130 EVR (11.9%), adjunctive drug coated balloons (DCB) in 498 (45.4%), additional stenting in 633 (57.8%). Debulking devices were used in 106 (9.7%) EVR. Clinical (Rutherford categories) and hemodynamic parameters (ankle-brachial-index) as well as secondary preventive medication were significantly improved post EVR. Periprocedural complications occurred in 63 (5.7%) EVR with pseudoaneurysm as the leading complication type in 26 (2.4%) EVR. Conclusions: The baseline data of the first 1000 patients from the RECCORD registry representing the real-world setting illustrate that the majority of EVR are performed in patients with claudication. Adjunctive use of DCB and stenting are the dominant types of EVR, while periprocedural complications are at an acceptable low rate.


Subject(s)
Registries , Aged , Aged, 80 and over , Angioplasty, Balloon , Demography , Female , Femoral Artery , Humans , Male , Middle Aged , Peripheral Arterial Disease , Popliteal Artery , Prospective Studies , Treatment Outcome , Vascular Patency
7.
Article in English | MEDLINE | ID: mdl-31186605

ABSTRACT

With the improving energy resolution of transitionedge sensor (TES) based microcalorimeters, performance verification and calibration of these detectors has become increasingly challenging, especially in the energy range below 1 keV where fluorescent atomic X-ray lines have linewidths that are wider than the detector energy resolution and require impractically high statistics to determine the gain and deconvolve the instrumental profile. Better behaved calibration sources such as grating monochromators are too cumbersome for space missions and are difficult to use in the lab. As an alternative, we are exploring the use of pulses of 3 eV optical photons delivered by an optical fiber to generate combs of known energies with known arrival times. Here, we discuss initial results of this technique obtained with 2 eV and 0.7 eV resolution X-ray microcalorimeters. With the 2 eV detector, we have achieved photon number resolution for pulses with mean photon number up to 133 (corresponding to 0.4 keV).

9.
J Low Temp Phys ; 193(3-4): 321-327, 2018 Nov.
Article in English | MEDLINE | ID: mdl-31186584

ABSTRACT

We have specialized astronomical applications for X-ray microcalorimeters with superconducting transition edge sensors (TESs) that require exceptionally good TES performance, but which operate in the small-signal regime. We have therefore begun a program to carefully characterize the entire transition surface of TESs with and without the usual zebra stripes to see if there are reproducible local "sweet spots" where the performance is much better than average. These measurements require precise knowledge of the circuit parameters. Here, we show how the Shapiro effect can be used to precisely calibrate the value of the shunt-resistor. We are also investigating the effects of stress and external magnetic fields to better understand reproducibility problems.

11.
Vasa ; 46(4): 262-267, 2017 Jul.
Article in English | MEDLINE | ID: mdl-28463077

ABSTRACT

BACKGROUND: The prevalence of peripheral artery disease (PAD) is increasing worldwide. Revascularization procedures constitute a cornerstone of the therapy in PAD, not only in critical limb ischaemia but increasingly also in patients with intermittent claudication. The German Society of Angiology - Society for Vascular Medicine is establishing a nationwide, prospective, multicentre registry to address the lack of contemporary real life data regarding current practice of medical and interventional care in vascular patients and its subsequent long-term outcome. PATIENTS AND METHODS: The RECording COurses of vasculaR Diseases registry (RECCORD registry) is an observational, prospective, multicentre, all-comers registry platform. In the initial phase, patients referred for endovascular revascularization of PAD of the lower limbs will be prospectively included and followed up for at least one year. At baseline, data on patients' demographic characteristics, comorbidities, previous peripheral interventions, medication, and clinical stage of PAD (Rutherford category), haemodynamic parameters, and procedural data including complications will be assessed. Major adverse cardiac and limb events will be recorded at planned (at six and 12 months) and at any unplanned visits. The therapeutic management will be exclusively left to the discretion of the vascular specialists. RESULTS AND CONCLUSIONS: The RECCORD registry will provide a comprehensive dataset depicting the current real life practice and outcome of vascular care. The seven predefined quality indicators will be used for benchmarking the participating centres. Moreover, identifying factors promoting a favourable outcome might pave the way for an evidence-based therapeutic strategy and a dedicated therapeutic pathway for patients with PAD including patient-oriented best interventional approaches. In the future, the RECCORD registry may provide a general platform to study the courses of various defined vascular diseases in order to get detailed insights into the real life current practice of health care provided to vascular patients.


Subject(s)
Biomedical Research/methods , Delivery of Health Care , Endovascular Procedures , Lower Extremity/blood supply , Peripheral Vascular Diseases/therapy , Registries , Benchmarking , Delivery of Health Care/standards , Endovascular Procedures/adverse effects , Endovascular Procedures/standards , Germany/epidemiology , Humans , Peripheral Vascular Diseases/diagnosis , Peripheral Vascular Diseases/epidemiology , Prospective Studies , Treatment Outcome
12.
Acta Gastroenterol Belg ; 80(1): 67-70, 2017.
Article in English | MEDLINE | ID: mdl-29364101

ABSTRACT

Aim Heterotopic gastric mucosa is a well-known congenital anomaly in Meckel's diverticula and duplication cysts. Solitary heterotopic gastric mucosa in the rectum is a rare and frequently overlooked abnormality. Starting from a patient history, the literature is searched and all cases reported over the past 20 years are reviewed and compared to a summary of the older cases. Differences between adult and childhood presentation are outlined and our patient is compared with prior reported cases. Case A 3-year-old girl presented with recurrent rectal blood loss caused by heterotopic gastric mucosa without duplication cyst. She was endoscopically treated with two-stage endoscopic surgical dissection (ESD). Up to now, rectal heterotopic gastric mucosa has been reported in 34 adults and 24 children, including this patient. There is an overall male dominance (69%). Presenting complaints in children were recurrent fresh blood loss per anum (96%), pain (46%), perineal ulcers (25%), diarrhoea (8%) and one patient had an ano-cutaneous fistula. Endoscopy revealed a mucosal elevation with a slightly different aspect (33%), a polyp (42%) and a solitary ulcer (25%). Endoscopy in adults reveals more frequently polyps compared to children. Treatment in childhood is mainly surgical where adults are more frequently treated with endoscopic techniques. Conclusion In a child with recurrent rectal bleeding in good general health, it is important to withhold heterotopic gastric mucosa in the differential diagnosis and take sufficient biopsies during endoscopy.


Subject(s)
Choristoma/complications , Choristoma/diagnosis , Gastric Mucosa , Gastrointestinal Hemorrhage/etiology , Intestinal Polyps/diagnosis , Rectal Diseases/etiology , Child, Preschool , Choristoma/surgery , Diagnosis, Differential , Endoscopy, Gastrointestinal , Female , Gastrointestinal Hemorrhage/surgery , Humans , Rectal Diseases/surgery , Recurrence
13.
J Low Temp Phys ; 184(1): 431-435, 2016 Jul.
Article in English | MEDLINE | ID: mdl-31359887

ABSTRACT

We report here a technique for processing microcalorimeter data that offers improved live-time over conventional optimal filtering techniques without loss of spectral resolution. Separate filters optimized for pulse amplitude and pulse arrival time (constructed in the usual way from the averaged signal and noise spectral densities) are applied to the entire pixel data stream. Pulses in the resulting filtered streams are then simultaneously fit as the sum of scaled and shifted copies of an isolated filtered pulse template. Analysis using calibration data from the University of Wisconsin/Goddard Space Flight Center X-ray Quantum Calorimeter (XQC) sounding rocket payload demonstrates the ability of this technique to recover pulses separated by as little as the rise-time of the detectors without observable spectral broadening.

14.
Biomed Res Int ; 2015: 719316, 2015.
Article in English | MEDLINE | ID: mdl-26146628

ABSTRACT

Arteriogenesis is an inflammatory process associated with rapid cellular changes involving vascular resident endothelial progenitor cells (VR-EPCs). Extracellular cell surface bound 20S proteasome has been implicated to play an important role in inflammatory processes. In our search for antigens initially regulated during collateral growth mAb CTA 157-2 was generated against membrane fractions of growing collateral vessels. CTA 157-2 stained endothelium of growing collateral vessels and the cell surface of VR-EPCs. CTA 157-2 bound a protein complex (760 kDa) that was identified as 26 kDa α7 and 21 kDa ß3 subunit of 20S proteasome in mass spectrometry. Furthermore we demonstrated specific staining of 20S proteasome after immunoprecipitation of VR-EPC membrane extract with CTA 157-2 sepharose beads. Functionally, CTA 157-2 enhanced concentration dependently AMC (7-amino-4-methylcoumarin) cleavage from LLVY (N-Succinyl-Leu-Leu-Val-Tyr) by recombinant 20S proteasome as well as proteasomal activity in VR-EPC extracts. Proliferation of VR-EPCs (BrdU incorporation) was reduced by CTA 157-2. Infusion of the antibody into the collateral circulation reduced number of collateral arteries, collateral proliferation, and collateral conductance in vivo. In conclusion our results indicate that extracellular cell surface bound 20S proteasome influences VR-EPC function in vitro and collateral growth in vivo.


Subject(s)
Blood Vessels/immunology , Collateral Circulation/immunology , Inflammation/immunology , Proteasome Endopeptidase Complex/immunology , Animals , Antibodies, Monoclonal/administration & dosage , Antibodies, Monoclonal/immunology , Antigens, Surface/immunology , Blood Vessels/growth & development , Cell Proliferation/drug effects , Endothelial Cells/immunology , Endothelial Progenitor Cells/immunology , Inflammation/pathology , Rats
15.
Vasa ; 44(1): 31-41, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25537056

ABSTRACT

BACKGROUND: Diabetes mellitus type II and arterial hypertension are major risk factors for peripheral arterial disease and have been considered to reduce collateral growth (arteriogenesis). Collateral growth proceeds through different stages. Vascular proliferation and macrophage accumulation are hallmarks of early collateral growth. MATERIAL AND METHODS: We here compare the impact of arterial hypertension and diabetes mellitus type II on collateral proliferation (Brdu incorporation) and macrophage accumulation (ED 2 staining) as well as collateral vessel function (collateral conductance) in a rat model of peripheral vascular disease (femoral artery occlusion), diabetes mellitus type II (Zucker fatty diabetic rats and Zucker lean rat controls) and arterial hypertension (induced via clip placement around the right renal arteriy). We furthermore tested the impact of monocyte chemoattractant protein-1 (MCP­1) on collateral proliferation and macrophage accumulation in these models RESULTS: Diabetic animals showed reduced vascular proliferation and macrophage accumulation, which however did not translate into a change of collateral conductance. Hypertensive animals on the contrary had reduced collateral conductances without altered macrophage accumulation and only a marginal reduction in collateral proliferation. Infusion of MCP­1 only enhanced vascular proliferation in diabetic animals. CONCLUSIONS: These findings illustrate that impaired monocyte/macrophage recruitment is responsible for reduced collateral growth under diabetic conditions but not in arterial hypertension suggesting that diabetes mellitus in particular affects early stages of collateral growth whereas hypertension has its impact on later remodeling stages. Successful pro-arteriogenic treatment strategies in a patient population that presents with diabetes mellitus and arterial hypertension need to address different stages of collateral growth and thus different molecular and cellular targets simultaneously.


Subject(s)
Collateral Circulation/physiology , Diabetes Mellitus, Type 2/physiopathology , Diabetic Angiopathies/physiopathology , Hypertension/physiopathology , Macrophages/cytology , Animals , Arteries/growth & development , Arteries/physiopathology , Diabetes Mellitus, Type 2/immunology , Diabetic Angiopathies/immunology , Disease Models, Animal , Hypertension/immunology , Macrophages/immunology , Obesity/immunology , Obesity/physiopathology , Rats, Zucker
16.
PLoS One ; 9(12): e114360, 2014.
Article in English | MEDLINE | ID: mdl-25490771

ABSTRACT

Alterations in bone remodeling are a major public health issue, as therapeutic options for widespread bone disorders such as osteoporosis and tumor-induced osteolysis are still limited. Therefore, a detailed understanding of the regulatory mechanism governing bone cell differentiation in health and disease are of utmost clinical importance. Here we report a novel function of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1), a member of the immunoglobulin superfamily involved in inflammation and tumorigenesis, in the physiologic regulation of bone remodeling. Assessing the expression of all members of the murine Ceacam family in bone tissue and marrow, we found CEACAM1 and CEACAM10 to be differentially expressed in both bone-forming osteoblasts and bone-resorbing osteoclasts. While Ceacam10-deficient mice displayed no alteration in structural bone parameters, static histomorphometry demonstrated a reduced trabecular bone mass in mice lacking CEACAM1. Furthermore, cellular and dynamic histomorphometry revealed an increased osteoclast formation in Ceacam1-deficient mice, while osteoblast parameters and the bone formation rate remained unchanged. In line with these findings, we detected accelerated osteoclastogenesis in Ceacam1-deficient bone marrow cells, while osteoblast differentiation, as determined by mineralization and alkaline phosphatase assays, was not affected. Therefore, our results provide in vivo and in vitro evidence for a physiologic role of CEACAM1 in the regulation of osteoclastogenesis.


Subject(s)
Cell Adhesion Molecules/deficiency , Osteoclasts/cytology , Animals , Antigens, CD/genetics , Bone Marrow/metabolism , Bone Remodeling , Cell Adhesion Molecules/genetics , Cell Line , Gene Expression Regulation , Mice , NFATC Transcription Factors/metabolism , Osteoblasts/cytology , Osteoblasts/metabolism , Osteoclasts/metabolism , Osteogenesis , Phenotype
17.
Neurogastroenterol Motil ; 26(6): 803-9, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24750284

ABSTRACT

BACKGROUND: Dumping syndrome is characterized by distinct pathophysiological features such as postprandial increase in hematocrit (HT) and pulse rate (PR) and delayed hypoglycemia (HG). Treatment is based on dietary measures and somatostatin analogs (SA), but current SAs have incomplete efficacy, possibly through limited affinity for various somatostatin receptor subtypes. We evaluated the effect of pasireotide, a novel SA with high affinity for 4/5 human somatostatin receptors, on pathophysiological events and symptoms in dumping. METHODS: Randomized double-blind placebo-controlled cross-over study of nine patients (six women, 47 ± 4 years) with postoperative dumping. Baseline measurements included oral glucose tolerance testing (OGTT), abdominal ultrasound, and dumping symptom severity score (DSSS). Patients were treated for 2 weeks with placebo or pasireotide 300 µg s.c. t.i.d. with a 1-week wash-out in a randomized fashion. On day 13 and 14 of each treatment OGTT, DSSS, and solid and liquid gastric emptying (GE) were obtained. KEY RESULTS: Baseline OGTT was pathological in all patients based on PR (n = 5), HT (n = 1) or HG (n = 7). Compared to placebo, pasireotide suppressed the increase in PR (17.1 ± 2.8 vs 8.2 ± 3.5 bpm; p < 0.05) and late HG (nadir glycemia 55.6 ± 4.3 vs 83.3 ± 9.5 mg/dL; p = 0.007), increased peak glycemia (294.1 ± 33.3 vs 221.0 ± 23.1 mg/dL; p = 0.001) and delayed GE of solids (t1/2 83 ± 23 vs 43 ± 9 min; p = 0.05) and liquids (t1/2 70 ± 10 vs 40 ± 4 min, p = 0.05). The differences in DSSS did not reach statistical significance. Two patients dropped out because of adverse gastrointestinal events under pasireotide. CONCLUSIONS & INFERENCES: Pasireotide affects pathophysiological features of both early and late dumping syndrome.


Subject(s)
Abdomen/surgery , Dumping Syndrome/drug therapy , Hormones , Postoperative Complications/drug therapy , Somatostatin/analogs & derivatives , Cross-Over Studies , Double-Blind Method , Dumping Syndrome/etiology , Dumping Syndrome/physiopathology , Female , Humans , Male , Middle Aged , Pilot Projects , Placebos , Severity of Illness Index , Somatostatin/administration & dosage , Somatostatin/pharmacology , Treatment Outcome
18.
Acta Gastroenterol Belg ; 76(3): 342-6, 2013 Sep.
Article in English | MEDLINE | ID: mdl-24261031

ABSTRACT

We report 3 male IBD patients (2 Crohn's Disease, 1 Ulcerative Colitis) developing thrombocytopenia and splenomegaly on azathioprine treatment. All patients were diagnosed with significant portal hypertension due to histological proven nodular regenerative hyperplasia (NRH) of the liver. In two of three patients, liver function tests remained completely normal. In addition we provide a short literature review of azathioprine induced NRH covering etiology, imaging, pathology, prognosis and treatment.


Subject(s)
Azathioprine/adverse effects , Hypertension, Portal/chemically induced , Inflammatory Bowel Diseases/drug therapy , Adult , Azathioprine/therapeutic use , Humans , Hypertension, Portal/physiopathology , Immunosuppressive Agents/adverse effects , Immunosuppressive Agents/therapeutic use , Male , Portal Pressure/drug effects
19.
Phys Rev A ; 88(5)2013 Nov.
Article in English | MEDLINE | ID: mdl-31360049

ABSTRACT

X-ray spectra following charge exchange collisions between C6+ and He are presented for collision energies between 460 eV/u and 32,000 eV/u. Spectra were obtained at the Oak Ridge National Laboratory Multicharged Ion Research Facility using a microcalorimeter X-ray detector capable of fully resolving the C VI Lyman series lines through Ly-γ. These line ratios are sensitive to the initial electron l-distribution and test our understanding of the charge exchange process. In addition, these line ratios are important for identifying charge exchange in astrophysical contexts involving the interaction of solar wind ions with neutrals. Our measurements are performed at collision velocities (300 km/s to 2500 km/s) which overlap most of the solar wind range. Additional data of this type can be combined with computations to provide an extensive set of reliable line ratios and absolute cross sections for the interpretation of a variety of astrophysical situations.

20.
Zootaxa ; 3737: 280-8, 2013 Nov 20.
Article in English | MEDLINE | ID: mdl-25112755

ABSTRACT

Telescopus finkeldeyi sp. nov. is described from western central to northern Namibia and south-western Angola. Its maximum size is less than that of the other three taxa occurring in southern Africa. It is further distinguished by its fairly variable colour pattern. Although the number of ventrals and the undivided anal scale are similar to that of T. beetzii, the presence of 19 scale rows around the middle differs from the 21 rows of T. beetzii.


Subject(s)
Colubridae/classification , Angola , Animals , Colubridae/anatomy & histology , Namibia
SELECTION OF CITATIONS
SEARCH DETAIL
...